2026. Design, Synthesis, and In-silico Evaluation of Benzyl oxybenzoate Derivatives as Dual HDAC Inhibitors for Cancer and CNS Disorders. Al Mustansiriyah Journal of Pharmaceutical Sciences. 25, 5 (Jan. 2026), 917–930. DOI:https://doi.org/10.32947/ajps.v25i5.1307.